Position in XERS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,379,888
+$4,827,511 QoQ
Shares Held
1,058,067
+72.8% QoQ
Ownership
0.580%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. XERS ranks #21 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in XERS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,379,888 | 1,058,067 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,552,377 | 612,479 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,026,211 | 895,059 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,367,315 | 905,076 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $4,820,661 | 1,032,262 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $11,609,750 | 2,114,709 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,537,263 | 1,043,441 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,117,083 | 391,960 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $729,905 | 324,403 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $827,322 | 374,355 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $757,723 | 322,436 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $217,537 | 116,956 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $792,172 | 302,356 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,249,053 | 766,291 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $125,574 | 94,418 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $131,541 | 84,322 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $122,598 | 79,610 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $47,756 | 18,655 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $38,842 | 13,257 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||